94 related articles for article (PubMed ID: 23298185)
1. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
Brett A; Pandey S; Fraizer G
Mol Cancer; 2013 Jan; 12():3. PubMed ID: 23298185
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics.
Rather MI; Swamy S; Gopinath KS; Kumar A
J Biol Chem; 2014 Jan; 289(2):968-76. PubMed ID: 24257751
[TBL] [Abstract][Full Text] [Related]
3. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.
Huang CF; Lira C; Chu K; Bilen MA; Lee YC; Ye X; Kim SM; Ortiz A; Wu FL; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2010 Jun; 70(11):4580-9. PubMed ID: 20484040
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis.
Lee YC; Bilen MA; Yu G; Lin SC; Huang CF; Ortiz A; Cho H; Song JH; Satcher RL; Kuang J; Gallick GE; Yu-Lee LY; Huang W; Lin SH
Mol Cancer Res; 2013 Nov; 11(11):1401-11. PubMed ID: 23913163
[TBL] [Abstract][Full Text] [Related]
5. Effects of Red Sorghum-Derived Deoxyanthocyanidins and Their O-β-D-Glucosides on E-Cadherin Promoter Activity in PC-3 Prostate Cancer Cells.
Mora N; Rosa M; Touaibia M; Martin LJ
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675711
[TBL] [Abstract][Full Text] [Related]
6. Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition.
Sinha S; Thomas D; Yu L; Gentles AJ; Jung N; Corces-Zimmerman MR; Chan SM; Reinisch A; Feinberg AP; Dill DL; Majeti R
Blood; 2015 Jan; 125(2):316-26. PubMed ID: 25398938
[TBL] [Abstract][Full Text] [Related]
7. WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups.
Krauth MT; Alpermann T; Bacher U; Eder C; Dicker F; Ulke M; Kuznia S; Nadarajah N; Kern W; Haferlach C; Haferlach T; Schnittger S
Leukemia; 2015 Mar; 29(3):660-7. PubMed ID: 25110071
[TBL] [Abstract][Full Text] [Related]
8. The application, safety, and future of
Einloth KR; Gayfield S; McMaster T; Didier A; Dworkin L; Creeden JF
Bioimpacts; 2023; 13(6):439-455. PubMed ID: 38022382
[TBL] [Abstract][Full Text] [Related]
9. A Nucleus-Targeting WT1 Antagonistic Peptide Encapsulated in Polymeric Nanomicelles Combats Refractory Chronic Myeloid Leukemia.
Chen M; Fang X; Du R; Meng J; Liu J; Liu M; Yang Y; Wang C
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765274
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific genetic variants associated with adult-onset inguinal hernia in a Taiwanese population.
Yen HC; Chen IC; Lin GC; Ke YY; Lin MC; Chen YM; Hsu CC
Int J Med Sci; 2023; 20(5):607-615. PubMed ID: 37082733
[No Abstract] [Full Text] [Related]
11. The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition.
Subbalakshmi AR; Sahoo S; Manjunatha P; Goyal S; Kasiviswanathan VA; Mahesh Y; Ramu S; McMullen I; Somarelli JA; Jolly MK
J Biol Eng; 2023 Mar; 17(1):17. PubMed ID: 36864480
[TBL] [Abstract][Full Text] [Related]
12. WT1: The Hinge Between Anemia Correction and Cancer Development in Chronic Kidney Disease.
Lee WC; Chiu CH; Chu TH; Chien YS
Front Cell Dev Biol; 2022; 10():876723. PubMed ID: 35465313
[TBL] [Abstract][Full Text] [Related]
13. Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer.
Long MD; Jacobi JJ; Singh PK; Llimos G; Wani SA; Rowsam AM; Rosario SR; Hoogstraat M; Linder S; Kirk J; Affronti HC; Bergman A; Zwart W; Campbell MJ; Smiraglia DJ
Cell Rep; 2021 Dec; 37(11):110109. PubMed ID: 34910907
[TBL] [Abstract][Full Text] [Related]
14. Declining levels of miR-382-3p at puberty trigger the onset of spermatogenesis.
Gupta A; Mandal K; Singh P; Sarkar R; Majumdar SS
Mol Ther Nucleic Acids; 2021 Dec; 26():192-207. PubMed ID: 34513304
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer.
Beveridge DJ; Richardson KL; Epis MR; Brown RAM; Stuart LM; Woo AJ; Leedman PJ
Sci Rep; 2021 Sep; 11(1):18003. PubMed ID: 34504167
[TBL] [Abstract][Full Text] [Related]
16. WT1 inhibits AML cell proliferation in a p53-dependent manner.
Yao Y; Chai X; Gong C; Zou L
Cell Cycle; 2021 Aug; 20(16):1552-1560. PubMed ID: 34288813
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor 1 (
Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
[TBL] [Abstract][Full Text] [Related]
18. Genomics and Functional Genomics of Malignant Pleural Mesothelioma.
Cakiroglu E; Senturk S
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882916
[TBL] [Abstract][Full Text] [Related]
19. Ca
Gross S; Mallu P; Joshi H; Schultz B; Go C; Soboloff J
Adv Cancer Res; 2020; 148():233-317. PubMed ID: 32723565
[TBL] [Abstract][Full Text] [Related]
20. Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines.
Sarne V; Huter S; Braunmueller S; Rakob L; Jacobi N; Kitzwögerer M; Wiesner C; Obrist P; Seeboeck R
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
